Rutecki P - Search Results

1

Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy.

Gidal BE, DeCerce J, Bockbrader HN, Gonzalez J, Kruger S, Pitterle ME, Rutecki P, Ramsay RE. Gidal BE, et al. Among authors: rutecki p. Epilepsy Res. 1998 Jul;31(2):91-9. doi: 10.1016/s0920-1211(98)00020-5. Epilepsy Res. 1998. PMID: 9714500 Free article. Clinical Trial.

2

Gabapentin absorption: effect of mixing with foods of varying macronutrient composition.

Gidal BE, Maly MM, Kowalski JW, Rutecki PA, Pitterle ME, Cook DE. Gidal BE, et al. Among authors: rutecki pa. Ann Pharmacother. 1998 Apr;32(4):405-9. doi: 10.1345/aph.17281. Ann Pharmacother. 1998. PMID: 9562133 Clinical Trial.

3

Lamotrigine pharmacokinetics in patients receiving felbamate.

Gidal BE, Kanner A, Maly M, Rutecki P, Lensmeyer GL. Gidal BE, et al. Among authors: rutecki p. Epilepsy Res. 1997 Apr;27(1):1-5. doi: 10.1016/s0920-1211(96)01018-2. Epilepsy Res. 1997. PMID: 9169285 Clinical Trial.

4

Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.

Gidal BE, Rutecki P, Shaw R, Maly MM, Collins DM, Pitterle ME. Gidal BE, et al. Among authors: rutecki p. Epilepsy Res. 1997 Oct;28(3):207-11. doi: 10.1016/s0920-1211(97)00053-3. Epilepsy Res. 1997. PMID: 9332885

5

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability.

Gidal BE, Radulovic LL, Kruger S, Rutecki P, Pitterle M, Bockbrader HN. Gidal BE, et al. Among authors: rutecki p. Epilepsy Res. 2000 Jul;40(2-3):123-7. doi: 10.1016/s0920-1211(00)00117-0. Epilepsy Res. 2000. PMID: 10863139 Clinical Trial.

6

Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs.

Rutecki PA, Gidal BE. Rutecki PA, et al. Epilepsy Behav. 2002 Dec;3(6S1):24-31. doi: 10.1016/s1525-5050(02)00539-5. Epilepsy Behav. 2002. PMID: 12609309

7

A 13-year-old with an acute change in mental status.

Gidal BE, Seltz JN, Rutecki P. Gidal BE, et al. Among authors: rutecki p. Semin Pediatr Neurol. 1999 Sep;6(3):146-9; discussion 149-50. doi: 10.1016/s1071-9091(99)80004-7. Semin Pediatr Neurol. 1999. PMID: 10522330

8

Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.

Gidal BE, Walker JK, Lott RS, Shaw R, Speth J, Marty KJ, Rutecki P. Gidal BE, et al. Among authors: rutecki p. Seizure. 2000 Mar;9(2):131-6. doi: 10.1053/seiz.1999.0372. Seizure. 2000. PMID: 10845738 Free article.

9

Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability.

Maganti R, Gidal BE, Shaw R, Rutecki P. Maganti R, et al. Among authors: rutecki p. Epilepsy Behav. 2002 Jun;3(3):275-279. doi: 10.1016/s1525-5050(02)00028-8. Epilepsy Behav. 2002. PMID: 12662609

10

Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.

Meek PD, Davis SN, Collins DM, Gidal BE, Rutecki PA, Burstein AH, Fischer JH, Leppik IE, Ramsay RE. Meek PD, et al. Among authors: rutecki pa. Arch Intern Med. 1999 Dec 13-27;159(22):2639-44. doi: 10.1001/archinte.159.22.2639. Arch Intern Med. 1999. PMID: 10597754 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page